We are international
Donate
TEXT SIZE   
   back

Dr. Davies - The Combination of Velcade, Idarubicin and Melphalan (VIM) Demonstrates Significant Clinical Activity in Relapsed/Refractory Myeloma Patients
Faith E. Davies, MD
The Royal Marsden NHS Foundation Trust
Sutton, Surrey, UK
Member, IMF Board of Scientific Advisors
01.02.08


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles